Covid-19: Second vaccine approved for use in UK and England’s tiers to be reviewed

The coronavirus vaccine designed by scientists at the University of Oxford

has been approved for use in the UK, and rollout will begin on 4 January. The UK has ordered 100 million doses from the manufacturer AstraZeneca – enough to vaccinate 50 million people – with the elderly, care home residents and health and care workers being given priority.